Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-20-001597
Filing Date
2020-02-14
Accepted
2020-02-14 12:55:47
Documents
2
Period of Report
2020-02-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3955
2 ex24_milne.htm EX-24 9113
  Complete submission text file 0001179110-20-001597.txt   14513
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Issuer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQ., BLDG. 1400E, STE.B14202 CAMBRIDGE MA 02139
Business Address
Milne Jill C. (Reporting) CIK: 0001644246 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37467 | Film No.: 20617097